Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Journal of Ovarian Research
Published in: Journal of Ovarian Research 1/2010

Open Access 01-12-2010 | Brief communication

Endometriosis-associated ovarian cancer: A ten-year cohort study of women living in the Estrie Region of Quebec, Canada

Author: Aziz Aris

Published in: Journal of Ovarian Research | Issue 1/2010

Login to get access

Abstract

Objectives

Endometriosis has been believed to increase the risk of developing ovarian cancer, but recent data supporting this hypothesis are lacking. The aim of this study was to verify whether the incidence of endometriosis, ovarian cancer and the both increased during the last 10 years among women living in the Estrie region of Quebec.

Methods

We collected data of women diagnosed with endometriosis, ovarian cancer or both, between 1997 and 2006, from a population living in the Estrie region of Quebec. We performed this retrospective cross-sectional study from the CIRESSS (Centre Informatisé de Recherche Évaluative en Services et Soins de Santé) system, the database of the CHUS (Centre Hospitalier Universitaire of Sherbrooke), Sherbrooke, Canada.

Results

Among the 2854 identified patients, 2521 had endometriosis, 292 patients had ovarian cancer and 41 patients had both ovarian cancer and endometriosis. We showed a constant increase in the number of ovarian cancer (OC) between 1997 and 2006 (r2 = 0.557, P = 0.013), which is not the case for endometriosis (ENDO) or endometriosis-associated ovarian cancer (EAOC). The mean age ± SD was 40.0 ± 9.9 and 53.9 ± 11.4 for patients having ENDO and OC, respectively. Mean age of women with EAOC was 48.3 ± 10.8, suggesting an early onset of ovarian cancer in women having endometriosis of about 5.5 years average, P = 0.003. Women with ENDO were at increased risk for developing OC (Rate Ratio [RR] = 1.6; 95% Confidence Interval [CI] = 1.12-2.09). Pathological analyses showed the predominance of endometrioid type (24.4%) and clear-cell type (21.9%) types in EAOC compared to OC, P = 0.0070 and 0.0029, respectively. However, the serous type is the most widespread in OC (44.5%) in comparison to EAOC (19.51%), P = 0.0023.

Conclusion

Our findings highlight that the number of cases of ovarian cancer is constantly increasing in the last ten years and that endometriosis represents a serious risk factor which accelerates its apparition by about 5.5 years.
Appendix
Available only for authorised users
Literature
1.
National Cancer Institute of Canada: Annual report. Toronto 1999.
2.
Ozols RF, Bookman MA, Connolly DC, Daly MB, Godwin AK, Schilder RJ, Xu X, Hamilton TC: Focus on epithelial ovarian cancer. Cancer Cell 2004, 5: 19–24. 10.1016/S1535-6108(04)00002-9CrossRefPubMed
3.
Bell DA: Origins and molecular pathology of ovarian cancer. Mod Pathol 2005, 18(Suppl 2):S19–32. 10.1038/modpathol.3800306CrossRefPubMed
4.
Barlow DH, Kennedy S: Endometriosis: new genetic approaches and therapy. Annu Rev Med 2005, 56: 345–56. 10.1146/annurev.med.55.091902.103805CrossRefPubMed
5.
Berkley KJ, Rapkin AJ, Papka RE: The pains of endometriosis. Science 2005, 308: 1587–9. 10.1126/science.1111445CrossRefPubMed
6.
Ness RB, Grisso JA, Cottreau C, Klapper J, Vergona R, Wheeler JE, Morgan M, Schlesselman JJ: Factors related to inflammation of the ovarian epithelium and risk of ovarian cancer. Epidemiology 2000, 11: 111–7. 10.1097/00001648-200003000-00006CrossRefPubMed
7.
Brinton LA, Gridley G, Persson I, Baron J, Bergqvist A: Cancer risk after a hospital discharge diagnosis of endometriosis. Am J Obstet Gynecol 1997, 176: 572–9. 10.1016/S0002-9378(97)70550-7CrossRefPubMed
8.
Ness RB, Cramer DW, Goodman MT, Kjaer SK, Mallin K, Mosgaard BJ, Purdie DM, Risch HA, Vergona R, Wu AH: Infertility, fertility drugs, and ovarian cancer: a pooled analysis of case-control studies. Am J Epidemiol 2002, 155: 217–24. 10.1093/aje/155.3.217CrossRefPubMed
9.
Cahill DJ, Hull MG: Pituitary-ovarian dysfunction and endometriosis. Hum Reprod Update 2000, 6: 56–66. 10.1093/humupd/6.1.56CrossRefPubMed
10.
Modugno F, Ness RB, Allen GO, Schildkraut JM, Davis FG, Goodman MT: Oral contraceptive use, reproductive history, and risk of epithelial ovarian cancer in women with and without endometriosis. Am J Obstet Gynecol 2004, 191: 733–40. 10.1016/j.ajog.2004.03.035CrossRefPubMed
11.
Rossing MA, Daling JR, Weiss NS, Moore DE, Self SG: Ovarian tumors in a cohort of infertile women. N Engl J Med 1994, 331: 771–6. 10.1056/NEJM199409223311204CrossRefPubMed
12.
Ron E, Lunenfeld B, Menczer J, Blumstein T, Katz L, Oelsner G, Serr D: Cancer incidence in a cohort of infertile women. Am J Epidemiol 1987, 125: 780–90.PubMed
13.
Venn A, Watson L, Lumley J, Giles G, King C, Healy D: Breast and ovarian cancer incidence after infertility and in vitro fertilisation. Lancet 1995, 346: 995–1000. 10.1016/S0140-6736(95)91687-3CrossRefPubMed
14.
Wheeler JM: Epidemiology of endometriosis-associated infertility. J Reprod Med 1989, 34: 41–6.PubMed
15.
Van Gorp T, Amant F, Neven P, Vergote I, Moerman P: Endometriosis and the development of malignant tumours of the pelvis. A review of literature. Best Pract Res Clin Obstet Gynaecol 2004, 18: 349–71. 10.1016/j.bpobgyn.2003.03.001CrossRefPubMed
16.
Kobayashi H: Ovarian cancer in endometriosis: epidemiology, natural history, and clinical diagnosis. Int J Clin Oncol 2009, 14: 378–82. 10.1007/s10147-009-0931-2CrossRefPubMed
17.
Yoshikawa H, Jimbo H, Okada S, Matsumoto K, Onda T, Yasugi T, Taketani Y: Prevalence of endometriosis in ovarian cancer. Gynecol Obstet Invest 2000, 50(Suppl 1):11–7. 10.1159/000052873CrossRefPubMed
18.
Nezhat F, Datta MS, Hanson V, Pejovic T, Nezhat C: The relationship of endometriosis and ovarian malignancy: a review. Fertil Steril 2008, 90: 1559–70. 10.1016/j.fertnstert.2008.08.007CrossRefPubMed
19.
Cramer DW, Missmer SA: The epidemiology of endometriosis. Ann N Y Acad Sci 2002, 955: 11–22. discussion 34–6, 396–406 10.1111/j.1749-6632.2002.tb02761.xCrossRefPubMed
20.
Olive DL, Schwartz LB: Endometriosis. N Engl J Med 1993, 328: 1759–69. 10.1056/NEJM199306173282407CrossRefPubMed
21.
Borgfeldt C, Andolf E: Cancer risk after hospital discharge diagnosis of benign ovarian cysts and endometriosis. Acta Obstet Gynecol Scand 2004, 83: 395–400.CrossRefPubMed
22.
Kobayashi H, Sumimoto K, Moniwa N, Imai M, Takakura K, Kuromaki T, Morioka E, Arisawa K, Terao T: Risk of developing ovarian cancer among women with ovarian endometrioma: a cohort study in Shizuoka, Japan. Int J Gynecol Cancer 2007, 17: 37–43. 10.1111/j.1525-1438.2006.00754.xCrossRefPubMed
23.
Moll UM, Chumas JC, Chalas E, Mann WJ: Ovarian carcinoma arising in atypical endometriosis. Obstet Gynecol 1990, 75: 537–9.PubMed
24.
Deligdisch L, Penault-Llorca F, Schlosshauer P, Altchek A, Peiretti M, Nezhat F: Stage I ovarian carcinoma: different clinical pathologic patterns. Fertil Steril 2007, 88: 906–10. 10.1016/j.fertnstert.2006.12.035CrossRefPubMed
Metadata
Title
Endometriosis-associated ovarian cancer: A ten-year cohort study of women living in the Estrie Region of Quebec, Canada
Author
Aziz Aris
Publication date
01-12-2010
Publisher
BioMed Central
Published in
Journal of Ovarian Research / Issue 1/2010
Electronic ISSN: 1757-2215
DOI
https://doi.org/10.1186/1757-2215-3-2

Other articles of this Issue 1/2010

Journal of Ovarian Research 1/2010 Go to the issue

Research

Analysis of ovarian tumor pathology by Fourier Transform Infrared Spectroscopy

Research

Radiolabeling, biodistribution and gamma scintigraphy of noscapine hydrochloride in normal and polycystic ovary induced rats

Research

Identification and characterization of a spontaneous ovarian carcinoma in Lewis rats

Research

Effects of GnRH agonist treatment on steroidogenesis and folliculogenesis in the ovary of cyclic mice

Research

Expression of interleukin-1 (IL-1) ligands system in the most common endometriosis-associated ovarian cancer subtypes

Research

Leucine-rich alpha-2-glycoprotein-1 is upregulated in sera and tumors of ovarian cancer patients